Portage Biotech Inc.
PRTG
$8.10
-$1.01-11.09%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 92.46% | 95.24% | 73.63% | 72.02% | 73.65% |
| Total Depreciation and Amortization | -23.08% | -33.33% | -53.33% | -27.27% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -98.08% | -98.83% | -1,416.67% | -155.73% | -75.80% |
| Change in Net Operating Assets | 206.39% | 257.08% | -113.54% | 48.92% | 77.74% |
| Cash from Operations | 64.50% | 67.71% | 63.65% | 51.17% | 33.33% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -16.67% | -27.27% | 0.00% | -28.57% | -- |
| Issuance of Common Stock | -- | -79.86% | -100.00% | -99.84% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 112.12% |
| Cash from Financing | 26,625.00% | -80.08% | -125.64% | -101.32% | -100.19% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 84.98% | -102.48% | 63.08% | 40.50% | 87.77% |